business
Elan shares rise on drug hopes
SHARES in Elan rose as much as 7% yesterday after the drug company said its treatment for Crohn’s disease could be on the market sooner than expected.
Organisation: Vernalis
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC
